HAVN Life Sciences Inc. (HAVLF) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Biotechnologie Branche. Der Hauptsitz des Unternehmens ist in Port Moody, BC, Canada. Der aktuelle CEO ist Tim Moore.
HAVLF hat IPO-Datum 2021-01-08, 6 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $2.57K.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
